📅 2026 Update: Recent Changes in Zelnorm Lawsuits

Since the original article on Zelnorm lawsuits was written, several significant updates have occurred in the realm of drug liability claims. These changes reflect ongoing litigation and developments involving various medications, including the growth of lawsuits related to Ozempic and Depo-Provera. Readers can find more details and context in the original article further down the page.

🏥 Ozempic Lawsuits Consolidation

As of June 2026, there are 3,763 lawsuits against Ozempic and similar drugs in federal court in Pennsylvania. These lawsuits allege that these medications caused severe gastrointestinal injuries and vision loss. This consolidation indicates a substantial number of patients claiming harm from these drugs.

  • 📈 In recent months, the number of claims has steadily increased, reflecting growing concern about the safety of GLP-1 receptor agonists.

⚖️ Depo-Provera Lawsuit Growth

The litigation surrounding Depo-Provera has expanded significantly. By June 2026, over 5,500 cases were filed, alleging a connection between the contraceptive and the development of brain tumors.

  • 📅 The first meningioma lawsuit related to Depo-Provera was filed in October 2024, and the number of claims has continued to rise since then.

💼 Gardasil Settlement Update

In June 2026, Merck reached a settlement of over $50 million to resolve more than 200 Gardasil-related cases. This settlement includes cases that were previously dismissed in North Carolina and a long-running case in Los Angeles.

  • 🤝 This resolution may provide some financial relief to affected individuals and families.

📅 Processing Times for Ozempic and Depo-Provera

As of June 2026, no trials have yet occurred in the Ozempic multidistrict litigation (MDL), with bellwether trials expected to start in late 2026 or early 2027. The continued growth of the Depo-Provera MDL suggests ongoing processing of claims.

  • ⏳ The timeline for resolution remains uncertain, as many cases are still being prepared for trial.

📌 Key Points Summary

  • 🔹 Over 3,763 lawsuits against Ozempic consolidated in Pennsylvania.
  • 🔹 The Depo-Provera MDL has surpassed 5,500 cases.
  • 🔹 Merck settled over $50 million for Gardasil-related claims.
  • 🔹 No Ozempic trials have occurred yet, with bellwether trials anticipated soon.
  • 🔹 Ongoing legal activity continues to shape product liability claims in the pharmaceutical industry.

💡 Tips for Navigating Drug Liability Claims

Review the specifics of your situation with your attorney. Understanding the details of your case can help you make informed decisions.

📄 Document Your Medical History

Keep thorough records of your medical history. This includes any prescriptions, side effects experienced, and doctor visits related to the drug in question.

🏢 Contact Regulatory Agencies

Reach out to the FDA for information on drug safety and adverse events. They provide resources that can help you understand the risks associated with medications.

📝 Know Your Eligibility

If you experienced severe gastrointestinal injuries or vision loss after taking Ozempic, you may be eligible to file a lawsuit. Similarly, individuals diagnosed with brain tumors after using Depo-Provera can also seek legal action.

⏰ Be Aware of Deadlines

Pay attention to filing deadlines. The first Depo-Provera lawsuit was filed on October 1, 2024, and subsequent claims are subject to statutes of limitations.

🤝 Explore Nonprofit Legal Aid

Look into nonprofit organizations that offer free legal assistance for product liability claims. These organizations can provide valuable support without financial burden.

📊 Stay Informed on Legal Developments

Keep track of ongoing lawsuits and settlements in the pharmaceutical industry. Staying updated can help you understand the landscape of drug liability claims.

🏆 Free Options Ranked by User Reviews (2026)

Currently, no national paid service meets the review threshold for drug liability assistance. This section focuses on free government and nonprofit resources that can support individuals navigating these issues.

🥇 1. FDA Resources

The FDA provides information on drug safety and adverse events. They help individuals understand the risks associated with medications and how to report injuries.

  • 📄 Accessing FDA resources can guide patients in recognizing adverse effects and understanding their rights related to pharmaceutical injuries.

🥈 2. Legal Aid Organizations

Various nonprofit organizations offer free legal assistance for individuals pursuing product liability claims. They may help low-income individuals navigate complex legal systems.

  • 🤝 These organizations can connect you with legal resources and support, making it easier to pursue claims without financial strain.

🥉 3. Consumer Protection Agencies

Consumer protection agencies often provide information and resources for individuals harmed by defective products. They can assist in reporting issues and advocating for consumer rights.

  • 📞 Engaging with these agencies can empower individuals to take action against companies that produce harmful products.

4️⃣ State Health Departments

State health departments may offer resources related to public health and safety, including information on drugs and medical devices.

  • 📊 They can provide insights into ongoing investigations or safety warnings related to medications, assisting individuals in making informed decisions.

🔎 Key Points to Check Before Paying for Help

  • 🔍 Verify credentials and reviews of any service.
  • 🔍 Ensure the service specializes in product liability claims.
  • 🔍 Check for any hidden fees or costs.
  • 🔍 Look for testimonials from previous clients.

❓ Frequently Asked Questions

❓ What are the main claims in the Ozempic lawsuits?

The main claims in the Ozempic lawsuits involve allegations that the drug causes severe gastrointestinal injuries and vision loss. Many plaintiffs argue that the manufacturers did not adequately warn patients about these risks.

🧑‍⚕️ Who is eligible to file a lawsuit against Depo-Provera?

Individuals diagnosed with brain tumors after using Depo-Provera may be eligible to file a lawsuit. The claims focus on the alleged link between the contraceptive and the development of these tumors.

📅 What are the expected timelines for the Ozempic MDL?

As of June 2026, no trials have occurred in the Ozempic MDL. Bellwether trials are anticipated to begin in late 2026 or early 2027, but exact timelines remain uncertain.

💰 How much was the Gardasil settlement worth?

In June 2026, Merck agreed to a settlement of over $50 million to resolve more than 200 cases related to Gardasil. This settlement addresses both previously dismissed and ongoing cases.

🏛️ What role does the FDA play in drug liability claims?

The FDA provides information on drug safety, adverse events, and regulatory actions. They can assist individuals in understanding the risks of medications and reporting injuries.

📝 How can I find legal assistance for a drug liability claim?

Individuals can seek free legal assistance from nonprofit organizations specializing in product liability claims. These organizations can offer guidance and support without financial burden.

⚖️ Recent Cases Related to Drug Liability Claims

Recent court rulings highlight ongoing legal actions and settlements in the pharmaceutical sector, emphasizing the importance of product liability cases.

For more recent rulings, feel free to browse more rulings on the news page.

End of October 2026 Update






A Brief Guide to Filing a Zelnorm Lawsuit





What is Zelnorm?





Zelnorm, the brand name of Tegaserod, is a prescription medication used to relieve bloating, constipation and pain caused by Irritable Bowel Syndrome—a condition that causes constipation, diarrhea, bloating and stomach pain. Zelnorm is predominantly prescribed to women whose primary symptom is constipation; however, the medication is also administered to increase the frequency of bowel movements and relieve straining, stomach pain and bloating in men and women with chronic idiopathic constipation.  Zelnorm belongs to a class of medications known as serotonin agonists; it is effective by improving muscle movement and increasing the production of fluid in the bowels.

Zelnorm Lawsuit




Novartis, the maker of Zelnorm, recently notified the United States Food and Drug Administration that they will no longer sell Zelnorm to treat irritable bowel syndrome and chronic constipation in female patients below the age of 55. Novartis agreed to maintain supply for emergency situations only. Emergency situations are defined as events that pose life-threatening threats or are serious enough to qualify for immediate hospitalization.





Zelnorm Side Effects:



Zelnorm, like other prescription medications, yield numerous side effects. Please contact your doctor if any of these symptoms are persistent or particularly bothersome:



• Common Zelnorm Side Effects Include: Diarrhea; headache; nausea; bad gas; back or leg pain; joint problems; difficulty falling or staying asleep; runny nose; cold-like symptoms; and congestion





Some Zelnorm side effects may be more severe. If you experience any of the following symptoms labeled in the WARNING or SPECIAL PRECAUTIONS section, please contact your doctor immediately:



• Severe Zelnorm Side Effects Include: Hives; Itching; Rash; Swelling of the throat, tongue, lips, eyes or face; difficulty swallowing or breathing; and hoarseness.







Zelnorm: FDA Regulations History



On March 30th of 2007, the United States Food and Drug Administration asked Novartis to halt its U.S. marketing and sales of the drug because a safety analysis found an increased chance of stroke, heart attack and unstable angine (chest/heart pain) in patients using Zelnorm.



Only July 27th of 2007, the United States Food and Drug Administration permitted the restricted use of Zelnorm under a treatment investigational new drug program.





Zelnorm Legal History:



From the moment it was approved by the FDA to the time it was removed from the American market, the prescription medication Zelnorm faced an exorbitant amount of controversy. That being said, following its introduction in 2002, there was no significant Zelnorm lawsuit pursuing compensation related to adverse effects. Lack of Zelnorm lawsuits over the drug’s side effects continued through 2004, when a warning was added to reflect the increased chance of causing a condition that reduced blood flow from the large intestine. However, significant grounds for filing a Zelnorm lawsuit were not discovered until 2007.



In 2007, Novartis shared the results of multiple clinical trials concerning Zelnorm side effects. These studies found that 13 patients taking the drug suffered a heart attack—only one patient faced similar results under the placebo. The FDA concluded that Zelnorm side effects could be attributed towards the drug and requested that it be removed from the market. This removal sparked an influx of Zelnorm lawsuits.



Zelnorm lawsuits are filed by patients or the families of patients who were prescribed the drug, and as a result, developed the aforementioned Zelnorm side effects. That being said, a Zelnorm lawsuit will not award compensation merely for developing an adverse reaction following use. The ability to win a Zelnorm lawsuit revolves around the patient’s adherence to the drug’s intake instructions and an affirmed link between use and the development of Zelnorm side effects. If these two basic steps are achieved, a Zelnorm lawsuit will result in the delivery of compensation to the patient and/or his/her family. Zelnorm lawsuits provide a means to offset the costs associated with the development of severe adverse reactions: Zelnorm lawsuits provide compensation for medical costs, pain and suffering and lost wages due to missed work. To secure a settlement, your prospective Zelnorm lawsuit must be undertaken by a qualified



Following the drug's removal from the market, approximately 135 people filed a Zelnorm lawsuit. However, the results of these Zelnorm lawsuits have not been publicized. In 2010 Novartis announced that 124 people filing a Zelnorm lawsuit had received an out-of-court settlement. The company did not disclose the financial terms of these Zelnorm lawsuits.



At the time that the FDA announced the recall, it did not file a Zelnorm lawsuit against the manufacturer. Furthermore, the federal agency announced that it was willing to allow the drug to return to market at a later date if Novartis could identify a patient group for whom the benefits of taking the drug would be greater than the potential Zelnorm side effects. However, Novartis has not chosen to take advantage of this offer, thereby preventing itself from being the subject of any more Zelnorm lawsuits. Since the drug has not been available for 5 years, patients who are currently experiencing  Zelnorm side effects probably will not be able to file an effective Zelnorm lawsuit at this time.





Sources:



1.The United States National Library of Medicine



“Tegaserod” retrieved from: https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000251/



2. United States Food and Drug Administration



“Zelnorm Information” retrieved from:



https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm103223.htm



3. FDA Announces Discontinued Marketing of GI Drug, Zelnorm, for Safety Reasons retrieved from:



https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108879.htm